Division News

Philanthropies announce new program to support early-career scientists

Three of the nation’s largest philanthropies – the Howard Hughes Medical Institute, the Bill & Melinda Gates Foundation, and the Simons Foundation – have announced a new partnership to provide much needed research support to outstanding early-career scientists in the United States.

Through the new Faculty Scholars Program, the philanthropies will invest a total of $148 million in research support over the program’s first five years.

Duke research: Investigational therapy could attack cause of sickle cell crises

Marilyn Telen, MD leads small study that finds treatment for painful episodes of blood vessel obstruction in sickle cell anemia is currently limited to controlling pain, but an investigational therapy might be able to interfere with the underlying cause of these events, known as vaso-occlusion crises.

 

Grand Rounds 10/10/14: A Prolonged aPTT in the CCU

Medicine Grand Rounds on Fri., Oct. 10 at 8 a.m. in Duke Hospital room 2002 will feature Thom Ortel, MD, PhD, professor of medicine and pathology, chief of the Division of Hematology and medical director, Clinical Coagulation Laboratory. Dr. Ortel will present When Hoofbeats Aren't Horses.

Save the date 4/29/14: Thrombosis and hemostasis disorders guest lecture

The Thrombosis and Hemostasis Disorders Consortium will host a guest lecture Tues., April 29, from 8-9 a.m. in Duke North, Room 2003. Jane E. Freedman, MD, professor of medicine and director of Translational REsearch at UMass Memorial Heart & Vascular Center, will present "Circulating Transcripts and Athero-thrombotic Disease." Dr. Freedman will also attend a small group discussion from 11:30 a.m.-12:45 p.m. in MSRB II, Room 3090. Lunch will be provided and space is limited.

Telen presents landmark new sickle cell disease research

At the 55th American Society of Hematology Annual Meeting and Exposition in New Orleans this month, Marilyn Telen, MD, professor of medicine, presented new research that uncovers several important insights into the pathophysiology of sickle cell disease and thalassemia that may soon translate into the development of better, more targeted treatments for hundreds of thousands of patients worldwide. Dr.

Save the date 11/20/13: Thrombosis and Hemostasis research conference

The Thrombosis and Hemostasis Disorders Consortium will host a research conference from 9:30-10:30 a.m. on Weds., Nov. 20, in Duke North Room 2003. Bruce Furie, MD, professor of medicine at Harvard Medical School and chief of the Division of Hemostasis-Thrombosis at Beth Israel Deaconess Medical Center, will be the featured speaker. Dr.